Skip to main content

Accelerate Access for a First-in-Class Therapy Launch

See how one first-in-class therapy observed an average 21-percentage-point improvement in claim approval rates by empowering providers with CoverMyMeds’ support at launch.

access the case study
Two corporate colleagues consulting with one another at a computer

Navigating payer caution for a first-in-class therapy

For first-in-class therapy launches, health plans naturally apply evidence-based utilization management strategies due to limited real-world evidence, evolving guidelines and cost management considerations.

With prior auth as a necessary tool to establish clinical baselines, brands need embedded solutions that empower providers with support to navigate it efficiently.

Following launch, the Test experience delivered a consistent and sustained increase in performance, averaging 22 percentage points higher than the Control group across nine months.

From launch complexity to access execution

By supporting providers through necessary launch requirements, the brand observed higher claim approval rates compared to claims without CoverMyMeds support, helping key launch objectives including early patient starts, provider adoption and consistency across plans.

What’s inside the case study

  • Navigating Payer launch requirements

    Understanding utilization management for first-in-class launch therapies

  • Designing a strategy that scales

    The operational elements that make a prior auth strategy work at scale for your launch.

  • Examining observed approval rate lift

    Explor observed claim approval rate lifts and insights from common launch codes 70 and 75

case study

Accelerating Access for a First-in-Class Launch​

Learn how one first-in-class brand navigated a launch with a scalable program design that contributed to improved claim approval rates.

Access the case study

Fields marked * are required

By clicking Submit, I acknowledge that I have read the CoverMyMeds Privacy Policy
Chat with support